160 related articles for article (PubMed ID: 29520648)
21. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database.
Shubert CR; Bergquist JR; Groeschl RT; Habermann EB; Wilson PM; Truty MJ; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB
Surgery; 2016 Oct; 160(4):1080-1096. PubMed ID: 27522556
[TBL] [Abstract][Full Text] [Related]
22. Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database analysis.
Deng A; Wang C; Cohen SJ; Winter JM; Posey J; Yeo C; Basu Mallick A
Eur J Cancer; 2021 Apr; 147():17-28. PubMed ID: 33607382
[TBL] [Abstract][Full Text] [Related]
23. Utilization and determinants of adjuvant therapy among older patients who receive curative surgery for pancreatic cancer.
Davila JA; Chiao EY; Hasche JC; Petersen NJ; McGlynn KA; Shaib YH
Pancreas; 2009 Jan; 38(1):e18-25. PubMed ID: 18797424
[TBL] [Abstract][Full Text] [Related]
24. A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas.
Marmor S; Burke EE; Virnig BA; Jensen EH; Tuttle TM
Cancer; 2016 Nov; 122(21):3378-3385. PubMed ID: 27419382
[TBL] [Abstract][Full Text] [Related]
25. Completion of Adjuvant Chemotherapy After Upfront Surgical Resection for Pancreatic Cancer Is Uncommon Yet Associated With Improved Survival.
Altman AM; Wirth K; Marmor S; Lou E; Chang K; Hui JYC; Tuttle TM; Jensen EH; Denbo JW
Ann Surg Oncol; 2019 Nov; 26(12):4108-4116. PubMed ID: 31313044
[TBL] [Abstract][Full Text] [Related]
26. Is Neoadjuvant Therapy Sufficient in Resected Pancreatic Cancer Patients? A National Study.
de Geus SWL; Kasumova GG; Eskander MF; Ng SC; Kent TS; James Moser A; Vahrmeijer AL; Callery MP; Tseng JF
J Gastrointest Surg; 2018 Feb; 22(2):214-225. PubMed ID: 29235000
[TBL] [Abstract][Full Text] [Related]
27. Trends in the treatment of resectable pancreatic adenocarcinoma.
Raigani S; Ammori J; Kim J; Hardacre JM
J Gastrointest Surg; 2014 Jan; 18(1):113-23. PubMed ID: 24002769
[TBL] [Abstract][Full Text] [Related]
28. Impact of affordable care act on the treatment and outcomes for stage-IV colorectal cancer.
Jayakrishnan TT; Bakalov V; Chahine Z; Finley G; Monga D; Wegner RE
Cancer Treat Res Commun; 2020; 24():100204. PubMed ID: 32805532
[TBL] [Abstract][Full Text] [Related]
29. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.
Riediger H; Keck T; Wellner U; zur Hausen A; Adam U; Hopt UT; Makowiec F
J Gastrointest Surg; 2009 Jul; 13(7):1337-44. PubMed ID: 19418101
[TBL] [Abstract][Full Text] [Related]
30. External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pancreatic adenocarcinoma.
Kantor O; Talamonti MS; Lutfi W; Wang CH; Winchester DJ; Marsh R; Prinz RA; Baker MS
Surgery; 2016 Dec; 160(6):1466-1476. PubMed ID: 27614417
[TBL] [Abstract][Full Text] [Related]
31. The Impact of Delays to Definitive Surgical Care on Survival in Colorectal Cancer Patients.
Trepanier M; Paradis T; Kouyoumdjian A; Dumitra T; Charlebois P; Stein BS; Liberman AS; Schwartzman K; Carli F; Fried GM; Feldman LS; Lee L
J Gastrointest Surg; 2020 Jan; 24(1):115-122. PubMed ID: 31367895
[TBL] [Abstract][Full Text] [Related]
32. Trends in the use of pre-operative radiation for adenocarcinoma of the pancreas in the United States.
Burke EE; Marmor S; Portschy PR; Virnig BA; Cho LC; Tuttle TM; Jensen EH
HPB (Oxford); 2015 Jun; 17(6):542-50. PubMed ID: 25726950
[TBL] [Abstract][Full Text] [Related]
33. Peripancreatic soft tissue involvement: independent outcome predictor in patients with resected pancreatic adenocarcinoma.
Hamidian Jahromi A; Zibari GB; Jafarimehr E; Chu Q; Wellman GP; Shi R; Johnson LW; Shokouh-Amiri H
Int Surg; 2014; 99(1):62-70. PubMed ID: 24444272
[TBL] [Abstract][Full Text] [Related]
34. Pre-operative wait times in high-grade non-endometrioid endometrial cancer: Do surgical delays impact patient survival?
Nica A; Sutradhar R; Kupets R; Covens A; Vicus D; Li Q; Ferguson SE; Gien LT
Gynecol Oncol; 2022 Feb; 164(2):333-340. PubMed ID: 34895897
[TBL] [Abstract][Full Text] [Related]
35. Association of socio-economic status and stage of pancreatic cancer at time of surgery in a German setting.
Standop J; Kuhn Y; Glowka TR; Schaefer N; Overhaus M; Schmitz V; Hirner A; Kalff JC
Hepatogastroenterology; 2012; 59(120):2614-7. PubMed ID: 23178627
[TBL] [Abstract][Full Text] [Related]
36. Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study.
Zhou H; Zhang Y; Wei X; Yang K; Tan W; Qiu Z; Li S; Chen Q; Song Y; Gao S
Cancer Med; 2017 Nov; 6(11):2745-2756. PubMed ID: 28980417
[TBL] [Abstract][Full Text] [Related]
37. The Impact of Surgical Delays on Short- and Long-Term Survival Among Colon Cancer Patients.
Lo BD; Caturegli G; Stem M; Biju K; Safar B; Efron JE; Rajput A; Atallah C
Am Surg; 2021 Nov; 87(11):1783-1792. PubMed ID: 34666557
[TBL] [Abstract][Full Text] [Related]
38. Patterns of Adjuvant Chemotherapy Use and Association With Survival in Adults 80 Years and Older With Pancreatic Adenocarcinoma.
Mehtsun WT; McCleary NJ; Maduekwe UN; Wolpin BM; Schrag D; Wang J
JAMA Oncol; 2022 Jan; 8(1):88-95. PubMed ID: 34854874
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
Abdel-Rahman O
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
[TBL] [Abstract][Full Text] [Related]
40. Impact of Different Treatment Modalities on the Outcome of Pancreatic Cancer.
Khan M; Ashraf MI; Syed AA; Hanif F
J Coll Physicians Surg Pak; 2017 Aug; 27(8):470-474. PubMed ID: 28903837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
